Strategy

Our strategy is designed to achieve our ambition of being the world's leading allergen immunotherapy company for the long-term and deliver sustainable value to all our stakeholders: patients, the medical community, healthcare systems, colleagues, and our shareholder. 

To achieve our ambition, our strategy is based on four pillars:

Strengthen our core business

Secure and strengthen our established leadership positions in allergen immunotherapy
We have built strong positions in the markets in which we operate. To maintain and strengthen these positions, we shall actively manage the lifecycle of our products, develop regulatory foresight and invest in innovation whilst creating a platform for future growth.
• Continue lifecycle management
• Expand paediatric indications
• Deploy digital adherence solutions

Expand our core offering 

Broaden our AIT portfolio to address unmet needs and capture market share in high-value segments
We are committed to enhancing our product portfolio for the benefit of patients and healthcare professionals. We will expand our market presence through the combination of innovation and strategic portfolio additions.
• Develop new products
• Pursue strategic partnerships
• Enhance portfolio through innovation

Extend geographic presence

Extend our presence in untapped and high-growth markets through partnerships and local strategies
Whilst Europe and the U.S. remain core markets, Asia offers exceptional growth opportunities and strategic importance for long-term value creation. We shall focus on establishing leadership positions in key growth markets.
• Launch in China with partners
• Consolidate Nordic success
• Explore and enter new geographies

Pursue inorganic growth

Position Stallergenes Greer at the forefront of allergy care
To strengthen our competitiveness, we shall complete and broaden our portfolio by exploring additional and adjacent areas whilst maintaining AIT leadership.
• Explore adjacencies
• Broaden and complete portfolio
• Invest in next generation therapeutics

Achieving our 2035 Vision also requires new organisational capabilities across multiple dimensions. We are systematically building the skills, systems and culture necessary to execute our strategy with excellence in an increasingly complex and competitive environment.

Discover how we are building future capabilities

Our strategy explicitly incorporates environmental, social and governance considerations as foundational elements of our long-term vision. We recognise that sustainable growth requires balancing the needs of patients, employees, communities and our planet whilst delivering value to all stakeholders.

Discover how we create sustainable value